April 10, 2025

Study: LLMs Show Biases in Medical Decision-Making

Large language models recommend different care based on patients' race, housing status, income level, and sexual orientation, potentially amplifying health care disparities if deployed without safeguards, researchers find.

Conexiant

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

September 23, 2024

Physicians Urged to Scrutinize Employers Beyond Salary

Beyond salary and work-life balance, physicians seeking new roles should evaluate potential employers' governance, reward systems, and culture, according to a viewpoint published in JAMA Internal Medicine.

Conexiant

July 02, 2024

Black Docs Lacking Amid Growing Attacks on Diversity Programs

Research has shown that patients of color prefer seeing doctors of their own race — and some studies have shown health outcomes are better for Black patients seeing Black doctors.

KFF Health News

June 21, 2024

Judge Rules HHS Online Tracking Bulletin Unlawful

Judge rules in favor of AHA, declaring HHS's online tracking restrictions unlawful, impacting hospitals' use of web technologies for health information sharing.

Conexiant

October 29, 2024

Study: Parent Physicians Face $2M Pay Gap

Parent physicians face stark earning divides: mothers' pay drops with each child while fathers see raises, creating $2M career gap.

Conexiant

September 30, 2024

More Females Entering High-Paying Specialties

While female matriculants in high-paying surgical specialties jumped from 28.8% to 42.4% between 2008 and 2022, their representation in high-paying nonsurgical fields remained stagnant.

Conexiant

February 26, 2025

New Medical Malpractice Rules Issued by American Law Institute

The American Law Institute's first restatement of medical malpractice law shifts focus from customary practice to evidence-based medicine.

Conexiant

July 24, 2024

Pharma Accelerates Personalized Cancer Therapies

Pharmaceutical giants aim to reduce manufacturing turnaround time for personalized blood cancer treatments, potentially benefiting patients at risk of becoming too sick during the process. Notable profits have been generated from these therapies, and quicker manufacturing times could offer a competitive edge and increase treatment uptake.

Reuters